EXICURE, INC. (ticker: XCUR) is an NASDAQ-listed pharma company. DredgeCap's structured extraction of XCUR's SEC filings surfaces 7 active risk signals, including 6 late-filing signals, and 1 auditor-change signal. XCUR reported $0 in revenue and -$4.95M for the period ending 2025-12-31, with operating cash flow of -$8.55M. Cash and equivalents stood at $3.75M (down 70.1% year-over-year). Total assets of $14.04M exceed total liabilities of $10.12M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
XCUR Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for EXICURE, INC. (XCUR) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.